Entegris, Inc. — Q2 2011 Form 10-Q
Business context and reporting period
Entegris supplies products and services that purify, protect, and transport materials used in semiconductor and other high-technology manufacturing. This unaudited report covers the quarter ended July 2, 2011 and the six months then ended; comparisons are with the periods ended July 3, 2010. The company reports three segments: Contamination Control Solutions (CCS), Microenvironments (ME), and Specialty Materials (SMD).
Financial performance and liquidity
| Metric | Q2 2011 | Q2 2010 | Six months 2011 | Six months 2010 |
|---|---|---|---|---|
| Net sales | $209.2 million | $167.6 million | $412.3 million | $328.1 million |
| Gross margin | 45.5% | 46.0% | 44.5% | 45.8% |
| Operating income | $41.0 million | $26.4 million | $78.3 million | $48.7 million |
| Net income attributable to Entegris | $32.5 million | $18.4 million | $61.7 million | $34.9 million |
| Diluted GAAP EPS | $0.24 | $0.14 | $0.45 | $0.26 |
| Operating cash flow | Not separately reported by quarter | $63.2 million | $55.8 million |
- Q2 sales rose 25% year over year; management attributed growth primarily to volume. Favorable currency translation contributed $14.3 million to quarterly and $22.4 million to first-half year-over-year sales growth. Excluding currency, sales increased approximately 16% and 19%, respectively.
- Q2 gross margin declined 0.5 percentage points year over year, primarily reflecting slightly lower factory utilization; sequentially, it improved from 43.5% in Q1 2011 to 45.5%.
- At July 2, cash and cash equivalents were $189.4 million and short-term investments $2.0 million, versus $134.0 million in cash and no short-term investments at year-end 2010. Working capital was $357.5 million, up from $279.5 million.
- Six-month capital expenditures were $14.6 million; management expected approximately $30 million for 2011. Operating cash flow less reported property and equipment purchases was approximately $48.6 million.
- No short- or long-term debt was outstanding at July 2. A new $30 million revolving facility, maturing June 9, 2014, replaced a $60 million facility. The company reported covenant compliance and no immediate plans to borrow.
Material changes and segment results
- CCS Q2 sales rose 32% to $136.6 million and segment profit increased to $44.9 million from $28.6 million.
- ME Q2 sales rose 8% to $51.1 million, but segment profit fell to $8.6 million from $11.7 million, primarily due to less favorable sales mix and lower gross margins.
- SMD Q2 sales rose 30% to $21.4 million and segment profit increased to $4.3 million from $2.5 million.
- Q2 SG&A and R&D increased in dollars, but each declined as a percentage of sales. Interest expense also fell year over year, mainly because the company had no outstanding debt in 2011.
Outlook, commentary, and risks
- For Q3 2011, management forecast sales of approximately $180 million to $190 million and non-GAAP diluted EPS of $0.18 to $0.21. These are forward-looking estimates, not guarantees.
- Q2 other income included a $1.5 million gain associated with the sale of an equity-method investment. The transaction involved a $0.2 million loss on disposition offset by a $1.7 million currency-translation reclassification gain. Q2 interest expense included a $0.3 million accelerated write-off of debt issuance costs.
- The effective tax rate was 22.6% for Q2 2011. A $9.7 million reduction in the U.S. deferred-tax-asset valuation allowance benefited the rate; Malaysian tax incentives and lower rates in certain jurisdictions also contributed.
- In April 2011, Entegris acquired the remaining 30% interest in its Pureline subsidiary for $1.5 million; the subsidiary became wholly owned.
- Risks include semiconductor-industry cyclicality, pricing and competition, fixed-cost exposure, foreign-exchange movements, and reliance on international markets. Management identified potential effects of the 2011 Japan earthquake and tsunami on supply, costs, delivery, and demand; approximately 20% of historical revenue came from Japanese customers. No material adverse consequences had occurred by the filing date.
- The company said ordinary-course legal matters were not expected to have a material adverse effect. Management assessed disclosure controls as effective and reported no material change in internal control over financial reporting during the quarter.
Most important facts for investors to verify
- Whether Q3 sales and non-GAAP EPS guidance were achieved, and how actual results compare with the stated ranges.
- How much sales growth reflects underlying demand versus currency translation, and whether gross-margin pressure from utilization or product mix persists.
- Whether ME segment profitability recovers and whether the strong CCS growth continues.
- The sustainability of cash generation and the planned 2011 capital spending level.
- The precise revolving-credit covenant language: the filing describes a cash-flow leverage ratio of “at least 3.0 to 1.0,” wording investors should confirm against the credit agreement.
- The recurring versus one-time contribution of the tax-allowance release and investment-sale gain to reported earnings.